Capital Analysts, LLC Balchem Corp Transaction History

Capital Analysts, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$81.49 - $113.6 $173,166 - $241,400	-2,125 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$96.34 - $105.25 $12,042 - $13,156	125 Added 6.25%	2,125 $216,000
Q3 2019 Nov 12, 2019	SELL	$83.01 - $105.34 $32,373 - $41,082	-390 Reduced 16.32%	2,000 $198,000
Q2 2019 Aug 13, 2019	SELL	$90.69 - $102.96 $17,775 - $20,180	-196 Reduced 7.58%	2,390 $239,000
Q4 2018 Feb 13, 2019	BUY	$73.39 - $110.81 $11,081 - $16,732	151 Added 6.2%	2,586 $203,000
Q3 2018 Nov 07, 2018	BUY	$97.22 - $116.69 $486 - $583	5 Added 0.21%	2,435 $0
Q2 2018 Aug 03, 2018	SELL	$80.7 - $100.4 $16,140 - $20,080	-200 Reduced 7.6%	2,430 $0
Q4 2017 Feb 14, 2018	BUY	$79.39 - $87.71 $163,702 - $180,858	2,062 Added 363.03%	2,630 $212,000
Q4 2017 Feb 12, 2018	SELL	$79.39 - $87.71 $156,557 - $172,964	-1,972 Reduced 77.64%	568 $96,000
Q3 2017 Nov 06, 2017	BUY	$73.12 - $81.91 $185,724 - $208,051	2,540	2,540 $207,000

374

28.2M

267K

5.7K

Ticker BCPC
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 32,120,600
Market Cap $5.11B
Description
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal N...

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Analysts, LLC with notifications on news.